Back to User profile » Dr Cathleen Park
Papers published by Dr Cathleen Park:
Case report
HER2-ADC and HER2-TKI Overcomes HER2 Amplification as an Acquired Resistance to Zongertinib – A Case Report
Nagasaka M, Arter ZL, Park CJ, Sarkari A, Ou SI
Lung Cancer: Targets and Therapy 2026, 17:600499
Published Date: 14 May 2026
Case report
Incretin Receptor Agonist, Semaglutide, as a Treatment for Alectinib-Induced Excessive Weight Gain. A Case Report
Lee ATM, Park CJ, Arter ZL, Nagasaka M, Ou SHI
Lung Cancer: Targets and Therapy 2025, 16:199-203
Published Date: 25 December 2025
Case report
Successful and On-going Long-Term Disease Control (>24 Months) with Gilteritinib in an ALK+ NSCLC Patient with Brain Metastasis Who Has Progressed on Multiple ALK TKIs. A Case Report and Review of Literature on Gilteritnib
Ou SHI, Park CJ, Arter ZL, Nagasaka M
Lung Cancer: Targets and Therapy 2025, 16:139-145
Published Date: 22 October 2025